The clinical use of levosulpiride in retinal fluorangiography
Torrero, M.; Rosina, A.; Paneghel, D.; Bianchetti, L.; Fusi, L.; Vanzetti, M.
Minerva Anestesiologica 56(12): 1455-1457
1990
ISSN/ISBN: 0375-9393 PMID: 2100326 Document Number: 355786
The value of administering 25 mg of levosulpiride per os approximately one hour before the sodium fluorescein bolus used in fluorangiography is assessed in order to avoid to the onset of nausea and/or vomiting during and after the test. The study was performed in 35 patients. No nausea and/or vomiting was observed in over 90% of cases treated.